Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury

Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal hydrolase (UCH-L1) have been FDA-approved for clinical use in mild and moderate traumatic brain injury (TBI). Understanding sex differences in their diagnostic accuracy over time will help inform clinical practice. We sought to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Papa, Linda, Brophy, Gretchen M., Alvarez, Wilmer, Hirschl, Robert, Cress, Marshall, Weber, Kurt, Giordano, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363108/
https://www.ncbi.nlm.nih.gov/pubmed/37481589
http://dx.doi.org/10.1038/s41598-023-38804-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363108/
https://www.ncbi.nlm.nih.gov/pubmed/37481589
http://dx.doi.org/10.1038/s41598-023-38804-4

Ejemplares similares